Gómez Almaguer, D., Cantú Rodríguez, O. G., Gutiérrez Aguirre, C. H., Jaime Pérez, J. C., Tarin Arzaga, L. C., Sánchez Cárdenas, M., . . . Colunga Pedraza, P. R. (2016). Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study.
Cita Chicago Style (17a ed.)Gómez Almaguer, David, et al. Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study. 2016.
Cita MLA (9a ed.)Gómez Almaguer, David, et al. Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study. 2016.